Skip to main content English


Riem Gawish
Maga. Riem Gawish, MSc. PhDJunior PI, Senior PostDoc

Department of Medicine I
Position: Research Associate (Postdoc)

ORCID: 0000-0003-4267-2131
T +43 1 40400-51480


Acute Lung Injury; Allergy and Immunology; Cytokines; Macrophage Activation; Pneumonia; SARS Virus; Sepsis; Streptococcus

Research group(s)

Research interests

I am investigating the molecular mechanisms which drive immunopathology-induced tissue damage and try to identify the key determinants of recovery or organ failure in critical disease.

Techniques, methods & infrastructure

  • Mouse models of infection and sepsis, sterile inflammation and chronic viral infection
  • All standard Molecular Biology techniques

Selected publications

  1. Gawish, R. et al. (2022) ‘A neutrophil–B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4’, eLife, 11. Available at:
  2. Watzenboeck, M.L. et al. (2021) ‘Multi-omics profiling predicts allograft function after lung transplantation’, European Respiratory Journal, 59(2), p. 2003292. Available at:
  3. Gawish, R. et al. (2022) ‘ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology’, eLife, 11. Available at:
  4. Lang, C. et al. (2020) ‘Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient’, The Lancet Respiratory Medicine, 8(10), pp. 1057–1060. Available at:
  5. Gawish, R. et al. (2019) ‘Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1’, Cell Reports, 26(9), pp. 2394-2406.e5. Available at: